In patients with an STS score <3%, TAVI significantly reduced the composite of all-cause death or disabling stroke at one year compared to SAVR (1.5% vs 6.5%, p=0.042).
Does TAVI reduce the composite of all-cause death or disabling stroke compared to SAVR in patients with severe aortic stenosis at low surgical risk (STS <3%)?
This editorial highlights that while TAVI may reduce early death or disabling stroke compared to SAVR in low-risk patients, concerns remain regarding higher rates of early valve reintervention and long-term durability.
Absolute Event Rate: 1.5% vs 6.5%
p-value: p=0.042
low-risk patients, can I come in? Okay but we are not ready (yet).
Rodrigo Bagur (Mon,) conducted a editorial in Severe aortic stenosis (n=1,660). Transcatheter Aortic Valve Implantation (TAVI) vs. Surgical Aortic Valve Replacement (SAVR) was evaluated on All-cause death or disabling stroke (STS <3% stratum) (p=0.042). In patients with an STS score <3%, TAVI significantly reduced the composite of all-cause death or disabling stroke at one year compared to SAVR (1.5% vs 6.5%, p=0.042).